Pharmaceutical News Wrap Up: February 2014

The pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls, approvals and warning label changes, medical studies and other pharmaceutical news taking place across the country and world.

  • Uterine Surgical Technique is Linked to Abnormal Growths and Cancer Spread
    Concerns are arising about the safety of a surgical procedure called morcellation, which is performed on tens of thousands of women each year to remove fibroid tumors from the uterus. Problems associated with the procedure are most likely from the electrical device used by the physician, which has a rapidly spinning blade.
  • FDA Advisers Revisit Heart Risks Posed by Painkillers
    Some pain relievers are safer for the heart than others, according to U.S. health officials. Specifically, the key painkiller in Aleve tends to be safer than other anti-inflammatory drugs such as ibuprofen (Advil and Motrin). Also called non-steroidal anti-inflammatory drugs (NSAIDs), the FDA is discussing potential cardiac risks associated with the class of drugs.
  • Endocrine Society Calls for Longer, Larger Studies on Testosterone
    Not long after the FDA’s decision to further investigate the safety of low T treatments, the U.S. Endocrine Society is calling for a more thorough assessment of the risks and benefits associated with testosterone treatment in older men.
    This decision follows the results from two new studies linking testosterone treatments to increased heart risks.
Simmons Support Team
Simmons Hanly ConroyWritten by:

Editorial Team

The Simmons Hanly Conroy Editorial Team consists of journalists, writers and editors who strive to deliver accurate and useful information to families needing legal help. Our team works alongside the firm's attorneys and shareholders, as well as with medical professionals and other specialists, to keep all information relevant and helpful.